バイオエンジニアリング部門 メーリングリスト登録者各位                                     いつもお世話になっております. 下記の要領にて第51回「計測と力学-生体への応用」研究会(共催)を開催いた します. なお,本研究会は日本機械学会北海道支部バイオメカニクス懇話会第23回講演 会(主催)および 日本生体医工学会専門別研究会「バイオメカニクス研究会」第160回研究会 (共催)として開催いたします. 多数の皆様のご参加をお待ちしております. 主査 大橋 俊朗 ----------------------------------- 記 -------------------------------                                           2015年11月17日     日本機械学会バイオエンジニアリング部門「計測と力学―生体への 応用―」                   第51回研究会 主 催:日本機械学会北海道支部バイオメカニクス懇話会 共 催:日本機械学会北海道支部,日本生体医工学会専門別研究会「バイオメ カニクス研究会」                                                                                 主査 大橋 俊朗 下記の要領にて第51回「計測と力学-生体への応用」研究会(共催)を開催いた します. 多数の皆様のご参加をお待ちしております. 日 時:2016年6月24日(金),11:00〜12:00 場 所:北海道大学大学院工学研究院・工学部 大会議室A1-17室 http://www.eng.hokudai.ac.jp/building/?place=outer 講 演: 「Magnetic nanoparticles for new therapies and diagnosis」 Prof. M. Ricardo Ibarra Director, Instituto de Nanociencia de Arag溶 (INA) Universidad de Zaragoza, Spain Professor, Laboratorio de Microscopias Avanzadas (LMA) Universidad de Zaragoza, Spain Magnetic nanoparticles (MNPs) constitute nowadays a vast field of research due to the current and expected application in nanobiomedicine. The potential MNPs stems from the intrinsic properties of their magnetic cores, combined with the functionality acquired under an appropriate coating. The capability for loading and targeted controlled release of drugs is one of the main issues in cancer therapy (for recent reviews see [1,2]). The biofunctionalization of the nanoparticles surface make them suitable for magnetic separation based on the biomolecular recognition of biological moieties. New inmunomagnetic assays using magnetic nanoparticles provides a new route to quantize the results in biosensors. The presence of MNPs also perturb locally the hydrogen proton relaxation, this phenomenon is on the bases of the enhance MRI diagnostic using contrast agents. Targeting of these contrast agents could detect angiogenesis processes at early stages. In this talk a brief review of all these different applications will be depicted emphasizing the application of electromagnetic waves in new therapies based on magnetic hyperthermia. The case of dendritic cells (DCs) as main candidate for magnetic hyperthermia will be reported. Magnetic hyperthermia (MH) is based on the use of MNPs to selectively increase the temperature of MNP-loaded target tissues when applying an alternating magnetic field (AMF) in the range of radiofrequency. To date, all MH research has focused on heat generation in an attempt to elucidate the mechanisms for the death of MNP-loaded cells submitted to AMF. However, recent in vitro studies have demonstrated the feasibility of inducing dramatic cell death without increasing the macroscopic temperature during AMF exposure. Here, we show that the cell death observed following AMF exposure, specifically that of MNPs loaded dendritic cells (DCs) in culture, was caused by the release of toxic agents into the cell culture supernatants and not due to a macroscopic temperature increase.[3] We performed MH in vitro experiments to demonstrate that the supernatant of the cell culture following AMF exposure was highly toxic when added to control unloaded DCs, as this treatment led to nearly 100% cell death. Therefore, our results demonstrate that heat is not the only agent responsible for triggering cell death following MH treatment. This finding offers new perspectives for the use of DCs as the proverbial Trojan horse to vectorise MNPs to the target tumour area and these results further support the use of DCs as therapeutic agents against cancer when submitted to AMF. Furthermore, this discovery may help in understanding the mechanism of cell death mediated by exposure to AMF. [1] “Magnetic nanoparticles for drug delivery” M. Arruebo, R. Fernandez-Pacheco, M.R. Ibarra and J. Santamar誕. Nanotoday 2 (2007) 22, [2] “Magnetic nanoparticles for cancer therapy” G.F: Goya, V. Grazu and M.R. Ibarra. Current Nanoscience 4 (2008) 1-16, [3] “Induced cell toxicity originates dendritic cell death following magnetic hyperthermia treatment” L As地, G F Goya, A Tres & M R Ibarra. Cell Death and Disease 4, e596 doi:10.1038/cddis.2013.121 (http://www.nature.com/cddis) 問い合わせ先: 大橋 俊朗  北海道大学大学院工学研究院人間機械システムデザイン部門 Tel&Fax: 011-706-6424, Email: ohashi@eng.hokudai.ac.jp -- ************************************************** 大橋 俊朗(Toshiro Ohashi) 北海道大学大学院工学研究院人間機械システムデザイン部門 〒060-8628 札幌市北区北13条西8丁目 Tel/Fax: 011-706-6424 E-mail: ohashi@eng.hokudai.ac.jp **************************************************